Skip Navigation

Phase III Randomized Trial of Stereotactic Ablative Radiotherapy SAbR for Oligometastatic Advanced Renal Carcinoma SOAR

Brief Summary

Type:
Kidney

Study Type:
Treatment

Phase:
III

ClinicalTrials.gov Identifier:
NCT05863351

Study #:
STUDY00150795

Start Date:
Dec 18, 2023

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT05863351

View Complete Trial Details & Eligibility at ClinicalTrials.gov